T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
Antonio Di Stasi, Barbara Savoldo(University of North Carolina at Chapel Hill)
Cited by 523
Related Papers
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
|Journal of Clinical Investigation|2017|368
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
|Journal for ImmunoTherapy of Cancer|2022|72